《大行報告》匯豐研究下調中資保險股目標價 指平安及財險為行業喜愛股份
匯豐研究發表報告,指仍然對內險股長期具結構性吸引力抱正面看法,但目前僅低估值的因素未足以支持更樂觀看法,目前低息和市場波動仍是宏觀面的不利因素,而由下而上的基本因素亦未見突出。
該行指,內險股的償付能力比率仍然維持舒適的水平,不過若監管要求進一步明顯提高,則需要通過發行債券或削減股息作改善;而資產方面的壓測顯示,則反映今年的股本較目前的基本情境估算低15-38%,而內含值亦低14-24%。
該行又指,壽險的新業務價值前景未見亮點,預期下半年前業務量不大可能復甦,影響產品和代理策略。投資回報方面雖然暫時保持,但整體及淨回報前景看來仍具挑戰性。
該行普遍下調內險股目標價,行業內喜好中國平安(02318.HK)和中國財險(02328.HK)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.